get your abstract accepted – behind the scenes and top tips
DESCRIPTION
Get your abstract accepted – behind the scenes and top tips. The European Group for Blood and Marrow Transplantation. Members . Inger Anderson John Murray Thorunn Saevarsdottir Erik Aerts Aleksandra Babic Mairéad Ní Chonghaile Arno Mank Elisabeth Wallhult. - PowerPoint PPT PresentationTRANSCRIPT
EBMT Slide templateBarcelona
7 February 2008
The European Group for Blood and Marrow Transplantation
Get your abstract accepted
– behind the scenes and top tips
The European Group for Blood and Marrow Transplantation
The European Group for Blood and Marrow Transplantation
Members Inger Anderson
John MurrayThorunn Saevarsdottir
Erik AertsAleksandra Babic
Mairéad Ní ChonghaileArno Mank
Elisabeth Wallhult
The European Group for Blood and Marrow Transplantation
Aims of the Committee• To coordinate and organise the following:
– Annual Conference– Annual Pre-Meeting Study Day– Educational activities
• To achieve accreditation and recognition of these educational activities
• To liaise/collaborate with physicians of EBMT in planning
educational activities • To explore options for developing an accreditation process within
EBMT
The European Group for Blood and Marrow Transplantation
Wanted - Abstracts
The European Group for Blood and Marrow Transplantation
Statistics
EBMT - Nurses Abstract Submission Statistics
133114 111
134 145169
134151
172 165 155 166
114
020406080
100120140160180200
Year
Nr.
of A
bstra
cts
The European Group for Blood and Marrow Transplantation
EBMT 2012 Abstract Submission Statistics Nurses by Country
35
1510 9 9
5 5 3 3 2 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 105
10152025303540
United
Italy
Netherlands
Israel
Switzerland
France
Spain
Czech
Denm
ark
Finland
Ireland
Saudi
USA
Australia
Austria
Belgium
Brazil
Bulgaria
Canada
Estonia
Germ
any
Lebanon
Om
an
Portugal
Serbia
Sweden
Turkey
The European Group for Blood and Marrow Transplantation
Abstracts submitted by topic
8
13
8 7
1
13
25
2
21
8
16
11
4 4
0
5
10
15
20
25
24. Care of thecare-giver
25.Com
plementary
26. Donor issues
27. Ethicalissues
28. Impact of
new therapies on
29. Outpatient
developments
30. Paliative andEnd of life care
31. Patientinform
ation and
32. Protectivecare
33. Psycho-social issues
34. Sexuality
35. Standards ofcare
36. Symptom
sm
anagement
37. Educationand support of
38. Managem
ent
39. Survivorshipand late effects
40. Quality of
life
The European Group for Blood and Marrow Transplantation
What is an abstract A self-contained, short and powerful
statement that describes a larger piece of work
Components vary Reasons vary
Articles Conferences
The European Group for Blood and Marrow Transplantation
Abstract
• Watch word/character limit• Present finished product and/or results• Language/grammar• Terminology• Not presented before
The European Group for Blood and Marrow Transplantation
Oral Presentation
20 minutes15 for presentation 5 for questions
EnglishEuropean Terminology (be careful of national
terms/standards)
The European Group for Blood and Marrow Transplantation
Poster Presentations
• Thought provoking• Check the size (only finalised in
acceptance letter)• Time to meet authors• Stay in place for 2.5 days
The European Group for Blood and Marrow Transplantation
Poster Presentation• Integral & Important part of meeting
• Important to attendees who do not have English as a first language
• Time to read & digest
• Time to meet authors
The European Group for Blood and Marrow Transplantation
Overview • the clarity of the abstract - is it clear what is being
described and how it was achieved or performed • the relevance of the abstract subject matter to the field of
haematopoietic stem cell transplantation • If the abstract describes a research project are the
results available for presentation • Remember that it will be possible to ask authors who do
not have English as a first language to correct or amend the language/spelling in the abstract if that is necessary.
• Not all abstracts need to be research project but can reflect innovations in practice and care.
The European Group for Blood and Marrow Transplantation
Nursing• Topic:
Is the topic significant, important, or relevant to BMT nursing? Is the role or contribution of/to nursing described?
• Purpose, Background and Rationale: Does the purpose clearly describe the project or activity? Is the background of the problem summarized? Is the conceptual model/rationale described? In the case of clinical and evidence based practice is the rationale for the topic logical and supported by the clinical information presented?
• Interventions: Does the intervention or practice describe how the purpose was accomplished? Are the interventions or practices described appropriately for the topic?
• Evaluation: Are the project goals evaluated according to specific measures? Are the outcomes applicable to BMT nursing?
The European Group for Blood and Marrow Transplantation
• Discussion:
Are the implications for BMT nursing practice identified? Are the suggestions for using the information included?
• Presentation: Is the abstract well written? Are the ideas clearly communicated?
• Is this an innovative, cutting-edge topic?• Are there any ethical implications or considerations?
The European Group for Blood and Marrow Transplantation
Research Study Abstracts
• Topic: Is the topic significant, important, or relevant to BMT nursing?
• Problem and Purpose: Is the problem well developed? Is the purpose of the study clearly stated?
• Theoretical or Scientific Framework: Is the theoretical base or philosophic frame of reference (for qualitativeresearch) clearly stated? Does it flow logically from the problem andpurpose?
• Methods: Are the design, sample, and data-collection instruments or methods usedto gather data described? Are they appropriate?
• Data Analysis: Is the data analysis or plan for the data analysis described? Is itappropriate?
The European Group for Blood and Marrow Transplantation
Research Study Abstracts
• Findings and Implications: Do the conclusions flow logically from the findings? Do the findingscontribute to practice or theory? If the work is in progress, is evidenceof preliminary findings present and/or implications for research, education,or practice?
• Presentation: Is the abstract well written? Are the ideas clearly communicated?
• Is this an innovative, cutting-edge study?• Are there any flaws in the study (e.g. topic not significant to nursing,
statistical errors, improper sampling) that should keep it from being presented?
• Are there any ethical implications or considerations?
The European Group for Blood and Marrow Transplantation
Next Conferences
2013 London7 – 10 April 2013
Abstract submission Date: 15th November 2012
2014 Milan30 March - 2 April 2014
2015 Istanbul22 - 25 March 2015